Skip to main content

Day: July 28, 2025

Blue Gold Limited Updates Shareholders on Strategic Growth and Vision to Become the World’s First Digital Gold Company

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Blue Gold Limited (Nasdaq: BGL) (“Blue Gold” or the “Company”), a next-generation gold development and technology company, today provided a shareholder update highlighting significant operational advancements, strategic initiatives, and its evolving vision to become the world’s first fully digital gold company. ASSET DEVELOPMENT AND STRATEGIC M&A Blue Gold continues to execute its growth strategy by focusing on high-quality, high-margin gold and copper assets: Strategic Pipeline: Blue Gold is actively evaluating accretive acquisition opportunities targeting 2 million ounces of annual production within five years and providing geographic diversification, underscoring its commitment to building a multi-asset, multi-jurisdictional gold producer. Mampon Copper/Gold License...

Continue reading

GOGL – Update on Merger with CMB.TECH and Change of VPS Registrar

Hamilton, Bermuda, 28 July, 2025 – Reference is made to the stock exchange announcement made by Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) (“Golden Ocean“) and CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH“) on 28 May 2025, where a merger between Golden Ocean and CMB.TECH was announced (the “Merger“). Assuming timely fulfillment of the relevant closing conditions, the parties aim to complete the Merger as soon as possible after the Golden Ocean Special General Meeting scheduled for 19 August 2025, currently expected on or around 20 August 2025, which will also be the first day of trading for the newly issued CMB.TECH Merger consideration shares on NYSE, Euronext Brussels and, tentatively, the first day of trading of CMB.TECH on Euronext Oslo Børs. It...

Continue reading

SEGG Media Highlights Lando Norris’ Belgian GP Appearance and Upcoming Quadrant Apparel Drop

A Media Snippet accompanying this announcement is available by clicking on this link. LONDON, July 28, 2025 (GLOBE NEWSWIRE) — SEGG Media Corporation (NASDAQ: SEGG, LTRYW) (“SEGG Media” or the “Company”), a leading technology company transforming the global intersection of sports, entertainment and gaming,   is proud to spotlight Lando Norris’ presence at the Belgian Grand Prix this past weekend, where the McLaren driver, Quadrant founder, and Veloce Media Group (“Veloce”) shareholder turned heads both on and off the track. Norris, who had a strong weekend at Spa, putting his McLaren MCL39 on pole position and dealing with treacherous conditions to finish on the podium, had already made headlines before the lights went out on Sunday. Arriving at the paddock on Thursday, Norris teased the release of the highly anticipated Quadrant...

Continue reading

Anthony Pompliano’s ProCap BTC LLC and Columbus Circle Capital Corp I Amend Business Combination Agreement to Provide Columbus Circle Capital Corp I Public Shareholders with Opportunity for Bitcoin Appreciation

New York, New York, July 28, 2025 (GLOBE NEWSWIRE) — ProCap BTC LLC (“ProCap BTC”), a Bitcoin-native financial services company and Columbus Circle Capital Corp I (“CCCM”) (Nasdaq: CCCM), have entered into an amendment (the “Amendment”) to their previously announced business combination agreement (the “Business Combination Agreement”), which is intended to provide CCCM public shareholders with exposure to the price appreciation of Bitcoin held on ProCap BTC’s balance sheet. This initiative is designed to benefit the CCCM public shareholders who choose not redeem their CCCM public shares in connection with the proposed business combination between the parties (the “Business Combination”)by providing them an opportunity to receive an additional number of shares of common stock of the go-forward public company, ProCap Financial,...

Continue reading

BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants.

July 28, 2025News Release BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants.Laboratory medicine continues to focus on kidney diagnostics.BioPorto is pleased to announce its attendance and the general multiple NGAL and Acute Kidney Injury (AKI) focused elements of the Association for Diagnostics Medicine meeting, this year held in Chicago from July 27 through 31, 2025. AKI continues to be a key topic for laboratory medicine due to the eGFR (estimated glomerular filtration rate) calculation changes and the transition and cycle of AKI to Chronic Kidney Disease (CKD). One of two AKI/NGAL special sessions1 is titled “Biomarkers of acute kidney injury in pediatrics: Focus on NGAL” by Nazim Bithi, PhD of Baylor College...

Continue reading

ServisFirst Bancshares, Inc. Ranks Fifth Among Top Publicly Traded Banks with between $10 Billion to $50 Billion in Assets

The Sole Alabama-Based Institution in the Top Ten BIRMINGHAM, Ala., July 28, 2025 (GLOBE NEWSWIRE) — ServisFirst Bank, a subsidiary of ServisFirst Bancshares (NYSE:SFBS), is pleased to announce they have ranked fifth in the top publicly traded banks with between $10 billion to $50 billion in assets, according to American Banker’s annual list of top-performing banks, based on year-end 2024 data. Compiled by Capital Performance Group using S&P Global Market Intelligence data and regulatory filings, the ranking recognizes banks delivering exceptional financial performance. Previously, ServisFirst Bancshares, Inc. was ranked fourth based on year-end 2023 data. “We are honored to once again be recognized among the top-performing banks in the country,” states Tom Broughton, ServisFirst Bank Chairman, President, and CEO. “Our...

Continue reading

Transom Capital Completes Acquisition of SigmaTron International

LOS ANGELES and ELK GROVE VILLAGE, Ill., July 28, 2025 (GLOBE NEWSWIRE) — Transom Capital Group (“Transom”), an operationally focused middle-market private equity firm, and SigmaTron International, Inc. (formerly NASDAQ: SGMA) (“SigmaTron” or the “Company”), a global electronic manufacturing services (EMS) provider, today announced the successful completion of Transom’s previously announced acquisition of SigmaTron. With the closing of the transaction, SigmaTron’s common stock has ceased trading and will no longer be publicly listed. “We are excited to embark on this next chapter in partnership with Transom,” said Gary Fairhead, Chairman and CEO of SigmaTron. “With Transom’s support and operational expertise, we are well positioned to accelerate our long-term strategic objectives, strengthen our customer partnerships and continue...

Continue reading

ScanTech AI Files Its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (SEC)

Company Reaffirms Commitment to Financial Transparency and Execution Discipline Atlanta, GA, July 28, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI),  a leading innovator in advanced security screening technologies, today announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the “Form 10-Q”), with the U.S. Securities and Exchange Commission (“SEC”). With this filing, the Company expects to resolve the deficiency relating to Nasdaq Listing Rule 5250(c)(1) for which the Company was in noncompliance as a result of not having timely filed the Form 10-Q. ScanTech AI remains committed to maintaining consistent and transparent financial disclosures moving forward. About ScanTech AI ScanTech AI Systems Inc. (Nasdaq:...

Continue reading

Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders

FREEHOLD, N.J., July 28, 2025 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that its subsidiary, Q&A Distribution, LLC, has entered into a wholesale distribution agreement with Saga Health Corporation (“Saga Health”) for its use of the KetoAir™ breathalyzer device in its first responder-targeted Holistic Health Reset Program. KetoAir™ is a handheld breathalyzer designed for ketogenic health management (U.S. Food and Drug Administration registration number: 3026284320). It measures breath acetone concentration (BrAce), a key indicator of fat metabolism and ketosis. Intended for users pursuing ketogenic diets for weight loss, athletic performance, or therapeutic purposes, the device utilizes nano-sensor...

Continue reading

Full Alliance Group Reports Second Quarter Preliminary results, Unveils Expansion into High-Growth Men’s Wellness Personal Care and Health Virility segment, Association Digital Benefits, and Expands its Contract Manufacturing Markets

TAMPA, Fla., July 28, 2025 (GLOBE NEWSWIRE) — Full Alliance Group, Inc. (OTC: FAGI) today announced preliminary unaudited revenue results for the second quarter of 2025 and provided an exciting outlook for the remainder of the year, driven by strategic expansion into rapidly growing multi-billion-dollar markets including men’s wellness, telehealth benefits, and contract manufacturing. Q2 2025 Financial Highlights (Pro Forma) Total Revenue: Estimated Revenue in excess of $750,000 versus 2024 Q2 Revenue of $508,097 at least a 47% Year over year increase.The company expects continued growth into Q3 2025, with projected revenues estimated at well over $1 million dollars, driven by new product launches, newly launched affiliate revenue, new manufacturing agreements, and DTC subscription momentum.  Men’s Wellness Division...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.